Guardant Health
GH
#1055
Rank
NZ$39.63 B
Marketcap
NZ$295.39
Share price
-1.32%
Change (1 day)
174.03%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): NZ-$6.07

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$6.24. In 2025 the company made an earnings per share (EPS) of NZ-$5.92 an increase over its 2024 EPS that were of NZ-$6.36.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.072.53%
2025NZ-$5.92-7.02%
2024NZ-$6.36-16.82%
2023NZ-$7.65-33.13%
2022NZ-$11.4460%
2021NZ-$7.1555.04%
2020NZ-$4.61207.14%
2019NZ-$1.50-19.81%
2018NZ-$1.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$0.06431-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.38-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA